Goal Concordant Care Learning Laboratory

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05879211
Collaborator
(none)
5,000
2
25

Study Details

Study Description

Brief Summary

The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Feedback
N/A

Detailed Description

The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness. The lab will test a variety of interventions, including triggered conversations and feedback to healthcare providers.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Several interventions will be tested, at the patient and provider levelsSeveral interventions will be tested, at the patient and provider levels
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Palliative Care Learning Laboratory
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Usual care

Experimental: Intervention

Feedback to provider regarding frequency and quality of communication

Behavioral: Feedback
Providers will receive detailed feedback about the timing, quality, and frequency of their goals of care communication with patients

Outcome Measures

Primary Outcome Measures

  1. Frequency of goals of care communication [2 years]

    Frequency of goals of care conversations in the last 6 months of life

  2. Timing of goals of care communication [6 months]

    Proximity of goals of care communication to death

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Duke Health patient
Exclusion Criteria:
  • None

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Duke University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05879211
Other Study ID Numbers:
  • Pro00106230
First Posted:
May 30, 2023
Last Update Posted:
May 30, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 30, 2023